Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and fourth most common cause of death in developed countries. Despite improved survival rates after resection combined with adjuvant chemotherapy or neoadjuvant chemotherapy, recurrence still occurs in a high percen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kole, Christo, Charalampakis, Nikolaos, Tsakatikas, Sergios, Frountzas, Maximos, Apostolou, Konstantinos, Schizas, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921671/
https://www.ncbi.nlm.nih.gov/pubmed/35300059
http://dx.doi.org/10.2147/CMAR.S267260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921671/
https://www.ncbi.nlm.nih.gov/pubmed/35300059
http://dx.doi.org/10.2147/CMAR.S267260

Ejemplares similares